Pilot 1B Study-Pharmacokinetics of MP-3180 and Use of Noninvasive Fluorescence Detection Device in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 01 Oct 2016
Price : $35 *
At a glance
- Drugs Relmapirazin (Primary) ; Iohexol
- Indications Acute kidney injury
- Focus Pharmacokinetics
- Sponsors MediBeacon
- 21 Sep 2016 Status changed from active, no longer recruiting to completed.
- 10 Jul 2015 Planned End Date changed from 1 Apr 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.
- 10 Jul 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.